DURECT CorpNASDAQ:DRRX
- LAST PRICE4.1100
- TODAY'S CHANGE (%)-0.2800 (-6.3781%)
- Bid / Lots4.1200/ 5
- Ask / Lots4.1900/ 3
- Open / Previous Close4.3900 / 4.3900
- Day Range
- 52 Week Range
- Volume65,119
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DRRX |
|---|---|---|
| 09:32 ET | 417 | 4.39 |
| 09:39 ET | 2252 | 4.39 |
| 09:56 ET | 1000 | 4.3541 |
| 10:12 ET | 200 | 4.33 |
| 10:14 ET | 100 | 4.32 |
| 10:17 ET | 100 | 4.31 |
| 10:19 ET | 400 | 4.3253 |
| 10:21 ET | 100 | 4.325 |
| 10:28 ET | 150 | 4.32 |
| 10:32 ET | 489 | 4.3 |
| 10:35 ET | 100 | 4.34 |
| 10:37 ET | 2251 | 4.25 |
| 10:42 ET | 700 | 4.295 |
| 10:50 ET | 313 | 4.3307 |
| 10:51 ET | 1599 | 4.2197 |
| 11:00 ET | 100 | 4.25 |
| 11:22 ET | 3099 | 4.23 |
| 11:24 ET | 100 | 4.22 |
| 11:33 ET | 1600 | 4.2 |
| 11:36 ET | 500 | 4.2248 |
| 11:38 ET | 1500 | 4.2 |
| 11:40 ET | 150 | 4.2273 |
| 11:42 ET | 200 | 4.17 |
| 11:56 ET | 200 | 4.22 |
| 12:12 ET | 350 | 4.22 |
| 12:16 ET | 100 | 4.2064 |
| 12:18 ET | 5463 | 4.1805 |
| 12:20 ET | 500 | 4.1883 |
| 12:21 ET | 1000 | 4.1912 |
| 12:25 ET | 200 | 4.2099 |
| 12:34 ET | 5300 | 4.185 |
| 12:36 ET | 122 | 4.2208 |
| 12:38 ET | 9985 | 4.15 |
| 12:39 ET | 1000 | 4.1675 |
| 12:45 ET | 1200 | 4.15 |
| 12:50 ET | 250 | 4.1499 |
| 12:52 ET | 500 | 4.16 |
| 12:57 ET | 240 | 4.174 |
| 01:03 ET | 100 | 4.1892 |
| 01:08 ET | 150 | 4.1772 |
| 01:21 ET | 100 | 4.1832 |
| 01:30 ET | 1089 | 4.14 |
| 01:42 ET | 627 | 4.13 |
| 01:44 ET | 299 | 4.12 |
| 01:48 ET | 100 | 4.1357 |
| 01:51 ET | 1051 | 4.12 |
| 01:57 ET | 200 | 4.14 |
| 02:00 ET | 100 | 4.14 |
| 02:04 ET | 5000 | 4.1499 |
| 02:06 ET | 7679 | 4.11 |
Mar 21, 2023
Durect Appoints Gail Maderis Board Chair; Shares Rise After Hours, from 5:01PM ET on Tuesday Mar 21, 2023 by MT Newswires
5:01PM ET on Tuesday Mar 21, 2023 by MT NewswiresBRIEF-Durect Announces Appointment Of Gail Maderis As Chair Of The Board, from 4:31PM ET on Tuesday Mar 21, 2023 by Thomson Reuters
4:31PM ET on Tuesday Mar 21, 2023 by Thomson ReutersDURECT Corporation Announces Appointment of Gail Maderis as Chair of the Board, from 4:30PM ET on Tuesday Mar 21, 2023 by PR Newswire
4:30PM ET on Tuesday Mar 21, 2023 by PR Newswire
Mar 14, 2023
--JonesTrading Initiates Durect at Buy With $37 Price Target, from 9:48AM ET on Tuesday Mar 14, 2023 by MT Newswires
9:48AM ET on Tuesday Mar 14, 2023 by MT Newswires
Mar 10, 2023
BRIEF-Durect Corp Does Not Maintain Any Accounts At Silicon Valley Bank, from 5:29PM ET on Friday Mar 10, 2023 by Thomson Reuters
5:29PM ET on Friday Mar 10, 2023 by Thomson Reuters
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
DURECT Corp | 107.5M | -2.6x | --- |
Celularity Inc | 85.8M | -3.4x | --- |
Milestone Pharmaceuticals Inc | 123.4M | -2.8x | --- |
Cellectis SA | 116.1M | -1.0x | --- |
Werewolf Therapeutics Inc | 82.9M | -1.3x | --- |
aTyr Pharma Inc | 104.7M | -1.4x | --- |
Company Information
Durect Corporation is a biopharmaceutical company that is focused on advancing lifesaving investigational therapies. The Company's product candidates include DUR-928 oral for metabolic/lipid disorders, and DUR-928, injectable for acute organ injuries. The Company’s other commercial product candidates include POSIMIR, PERSERIS and Methydur Sustained Release Capsules. The Company is conducting a Phase IIb study (AHFIRM) of larsucosterol (DUR-928) in subjects with alcohol-associated hepatitis (Alcoholic Hepatitis (AH) to evaluate the safety and efficacy of larsucosterol treatment. Larsucosterol (DUR-928) is lead product candidate, an endogenous sulfated oxysterol and an epigenetic regulator. The Company focuses on drug delivery technology around its SABER and CLOUD Bioerodible Injectable Depot Systems. SABER uses a high viscosity base component, such as sucrose acetate isobutyrate (SAIB), to provide controlled release of a drug. CLOUD is a class of bioerodible injectable depot technology.
Contact Information
- Headquarters
- 10260 Bubb RdCUPERTINO, CA, United States 95014
- Phone
- 408-777-1417
- Fax
- 408-777-3577
Executives
- Independent Chairman of the Board
- Gail Maderis
- President, Chief Executive Officer, Director
- James Brown
- Chief Financial Officer
- Timothy Papp
- Senior Vice President - Operations and Corporate Quality Assurance
- Judy Joice
- Interim Principal Accounting Officer
- Jian Li
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $107.5M |
|---|---|
Revenue (TTM) | $19.3M |
Shares Outstanding | 24.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.63 |
EPS | $-1.55 |
Book Value | $1.10 |
P/E Ratio | -2.6x |
Price/Sales (TTM) | 5.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -181.93% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
